Glenn A. Oclassen, President and CEO at Transcept Pharmaceuticals Inc (TSPT), bought 10,000 shares at $5.80 ($58K) on 2011-09-19, disclosed to the SEC on 2011-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |